Rockwell Medical Inc.

Rockwell Medical Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
51.77 M
Public Float
41.92 M
Rockwell Medical Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.66
Market Cap
$189.56 M
Shares Outstanding
63.4 M
Public Float
45.56 M

Profile

Address
30142 Wixom Road
Wixom Michigan 48393
United States
Employees -
Website http://www.rockwellmed.com
Updated 07/08/2019
Rockwell Medical, Inc. is a biopharmaceutical company, which operates through Hemodialysis Market segment that engages in the manufacture, sale, and distribution of hemodialysis products to hemodialysis clinics including pharmaceutical, dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. Its dialysis products include Triferic, Calcitriol Vitamin D Injection, Hemodialysis Concentrates, CitraPure, Dri-Sate, and ancillary products. The company was founded by Robert L.

Financials

View All

Stuart Paul
President, CEO, CFO & Director
Benjamin C. Wolin
Chairman